ISBN-13: 9783807003245 / Angielski / Miękka / 1981 / 524 str.
ISBN-13: 9783807003245 / Angielski / Miękka / 1981 / 524 str.
— Contents.- Virologic Aspects.- Herpesviruses — Common Properties and Heterogeneity.- Discussion on the Contribution pp. 3–12.- Herpes Simplex Virus Strain Specificity: Virulence Correlates.- Herpes Simplex Virus Strain Specificity and Ocular Disease.- Discussion on the Contributions pp. 15–23.- Latency.- Latency in Neuronal Tissues of Herpes Simplex and Varicella Zoster Virus.- Discussion on the Contribution pp. 27–31.- Trigeminal Nerve Lesions After Corneal HSV Infection.- Discussion on the Contribution pp. 33–35.- Infection With Herpes Simplex Virus in the Eye and Trigeminal Ganglion of Mice.- Mechanisms of Control of Latent Herpes Simplex Virus Infection in the Skin and Eye.- Discussion on the Contributions pp. 37–47.- Do Suppressor Lymphocytes Have a Role in Herpes Simplex Virus Latency and Recurrence?.- Aesthesiometrie bei Herpes corneae.- Discussion on the Contribution pp. 53–56.- Vaccination.- Prospects for an Effective Vaccination Against Herpes Viruses.- Discussion on the Contribution pp. 61–65.- Vaccination Against Herpes Simplex Viruses: Efficacy Against the Acute, Latent and Recurrent Infection.- Discussion on the Contribution pp. 67–71.- Immunogenetics.- HLA-Types and Herpes Simplex Ocular Infection.- HLA-DR Antigens and Recurrent Herpes Simplex Virus Infections.- Natural Killer Activity and HLA Phenotypes in Patients With Herpes Simplex Keratitis P*.- HLA Antigens in Recurrent Corneal Herpes Simplex Virus Infection P.- HLA Phenotypes in Patients With Herpetic Keratitis P.- Discussion on the Contributions pp. 75–97.- Atopy and Herpetic Keratitis.- Interference Between Ocular Herpes and Allergic Diseases. An Epidemiological Approach P.- Discussion on the Contributions pp. 101–107.- Immunology, Pathology.- The Influence of Antiviral Immunity in Epithelial Herpetic Keratitis.- Factors Influencing the Spread of Herpes Simplex Virus Into the Corneal Stroma.- Discussion on the Contributions pp. 111–127.- The Turnover of Lysosomal Particles During Corneal Herpetic Infection. A Morphometric Study.- Discussion on the Contribution pp. 129–136.- Unspecific Immunostimulation in Patients With Herpes Simplex Corneae Using BCG and Levamisole P.- Discussion on the Contribution pp. 137–144.- Herpetic Keratitis in Diet Deficient Animals. I. Zinc Deficiency.- Discussion on the Contribution p. 145.- Coefficient of Antibody Activity in the Acqeous Humour to That in the Serum in Ocular Herpes Simplex.- Changes of Immune Globulins in Different Herpetic Diseases P.- Zur Klinik der granulomatösen Reaktion gegen die Descemetsche Membran.- Granulomatous Keratitis and its Relationship to Herpetic Dissease P.- Discussion on the Contributions pp. 163–171.- Scanning Electron Microscopic Investigations on the Development of the Dendritic Lesion in the Corneal Epithelium P.- Discussion on the Contribution pp. 175–178.- Welcoming Address at the Wine Tasting Party.- Clinico-Serologic Correlations.- A Micro-Immunofluorescence (IF) Test for Detecting Type- Specific Antibodies to Herpes Simplex Virus.- Discussion on the Contribution p. 183.- Virologische Untersuchungen bei endogenen Augenerkrankungen.- Diskussion zum Beitrag S. 185–187.- Clinical Virology.- Herpetic Chorioretinitis in Newborn Infants: An Experimental Study.- Discussion on the Contribution pp. 191–198.- Herpes Simplex Blepharitis of the Erosive-Ulcerative Type P.- Discussion on the Contribution p. 201.- A Clinico-Virologic Classification of Herpetic Anterior Segment Disease with Special Reference to Intraocular Herpes P.- Discussion on the Contribution pp. 203–208.- Herpetic Keratitis Causing Lacrimal Hyposecretion and Xerosis.- Impairment of Tear Production in Corneal Herpetic Diseases.- Discussion on the Contribution pp. 211–218.- Antivirals.- Development of Antiviral Drugs.- Discussion on the Contribution pp. 223–228.- Animal Models in the Development of Antiviral Therapy.- Discussion on the Contribution pp. 229–235.- Molecular Basis and Pharmacological Consideration of Selective Antiherpetic Agents.- Discussion on the Contribution pp. 237–245.- Systemic Application of Antivirals for Herpes Infections.- The Chemotherapy of Herpetic Keratitis in Rabbits.- Discussion on the Contribution pp. 255–262.- Adverse Reactions in the Eye from Topical Therapy with Idoxuridine, Adenine Arabinoside and Triflurothymidine.- Discussion on the Contribution pp. 263–267.- The Cytotoxicity of Nucleoside Antivirals to Epithelial Cells of Ocular Origin P.- The Effect of Trifluorothymidine on Epithelial Wound Healing in Rabbit Cornea. A Scanning Electron Microscopic Study P.- Discussion on the Contribution pp. 227–284.- Der Einfluß von Virustatika und Steroiden auf die stromale Wundheilung P.- Diskussion zum Beitrag S. 287–289.- Trifluorthymidin und bakterielle Horn-hautinfektion P.- Diskussion zum Beitrag S. 291–294.- Acyclovir (Zovirax) in the Management of Herpetic Keratitis.- Discussion on the Contribution pp. 295–300.- Antiviral Agents in Experimental Herpetic Stromal Disease.- Discussion on the Contribution pp. 303–307.- Treatment of Acute and Chronic Ocular Herpes Infection With Acyclovir P.- Discussion on the Contribution pp. 309–314.- Studies of Acycloguanosine and Ara-AMP Against Herpetic Keratitis in Rabbits P.- The Clinical Use of Acyclovir in the Treatment of Herpes Simplex Corneal Ulceration.- Acyclovir (Zovirax) in Herpes Simplex Keratitis P.- Discussion on the Contribution pp. 323–327.- On the Mechanism of Anti-Herpes Action of E-5-(2-Bromovinyl)-2?-Deoxyuridine.- Efficacy of E-5-(2-Bromovinyl)-2?-Deoxyuridine in the Topical Treatment of Herpetic Keratitis in Rabbits and Man.- Discussion on the Contributions pp. 329–341.- The Efficacy of Some Newer Antiherpetic Compounds in the Rabbit Model.- Discussion on the Contribution pp. 343–344.- Evaluation of Glucosamine in HSV-Keratitis Therapy.- Discussion on the Contribution pp. 347–351.- Trifluorothymidine Sensitivity of Ocular Herpes Simplex Virus Strains P.- Discussion on the Contribution pp. 353–355.- Viral Drug Sensitivity in Cases of Herpes Simplex Ulceration P.- The Clinical Implications of Acyclovir-Resistant Mutants of Herpes Simplex Virus.- Discussion on the Contribution pp. 359–361.- Different Clinical Experiences.- Dendritic Keratitis — a Comparison of Different Therapy Forms With Special Emphasis on Antibody-Therapy.- Discussion on the Contribution pp. 365–371.- Zur thermischen Abrasio des Hornhaut-epithels P.- Discussion on the Contribution p. 373.- Longitudinal Analysis of Ulcerative Herpetic Keratitis.- Discussion on the Contribution pp. 375–379.- Trifluorothymidine and Adenine Arabinoside in the Treatment of Dendritic Keratitis P.- Discussion on the Contribution pp. 381–383.- Unterschiedliche Behandlungsprinzipien bei der herpetischen Keratitis und Keratouveitis und ihre klinischen Ergebnisse P.- Diskussion zum Beitrag S. 385–387.- Interferon.- Mechanisms of Interferon Action.- Discussion on the Contribution pp. 391–393.- Human Interferon in Topical Therapy of Herpetic Keratitis.- Discussion on the Contribution pp. 395–399.- Therapy and Prophylaxis of Dendritic Keratitis With Topical Human Interferon.- Discussion on the Contribution pp. 401–407.- Effect of Human Fibroblast Interferon on Dendritic Keratitis.- Discussion on the Contribution pp. 409–413.- Clinical Results of Treatment in Herpes Simplex Ocular Infection (The Effect of Poly I:C on the Inhibition of Ocular Herpes Simplex Virus in Vitro and in Vivo).- Keratoplasty.- Results of Keratoplasty in Metaherpetic Keratitis.- Discussion on the Contribution pp. 419–422.- Penetrating Keratoplasty for Herpes Simplex Keratitis.- Keratoplastik bei Herpes corneae. Vergleich zwischen klinischem und histopathologischem Befund an 100 Augen.- Prognosis and Management of Corneal Transplantation for Herpetic Keratitis.- Differential Diagnosis of Post-Keratoplasty Complications in Herpes Patients P.- Discussion on the Contributions pp. 425–444.- Zoster Ophthalmicus.- A Controlled Trial of Intravenous Therapy with Adenine Arabinoside (Ara-A) in Ophthalmic Zoster.- A Double-Blind Controlled Trial of Therapy with Levamisole in Ophthalmic Zoster.- The Use of Acyclovir in the Treatment of Herpes Zoster Ocular Infections.- Trials with Interferon in Ophthalmic Zoster P.- Discussion on the Contributions pp. 449–467.- Corneal Perforation in Herpes Zoster Ophthalmicus Caused by Eyelid Scarring with Exposure Keratitis P.- Cytomegalovirus Diseases.- Infections with Cytomegalovirus in Adults and the Natural History and Treatment of Cytomegalovirus Retinitis.- Discussion on the Contribution pp. 481–492.- Histopathological Study of Adult Cytomegalic Inclusion Retino-Uveitis P.- Discussion on the Contribution pp. 495–500.- Connatal Monosymptomatic Corneal Endotheliitis by Cytomegalovirus P.- Discussion on the Contribution pp. 501–504.- Summing-up.- Zusammenfassung.- Schlußwort.- List of Authors and Discussants.- Index and Key Words.- Verzeichnis der Schlüsselwörter.
1997-2024 DolnySlask.com Agencja Internetowa